首页> 外国专利> HIF-1 AND HIF-2 INHIBITORS

HIF-1 AND HIF-2 INHIBITORS

机译:HIF-1和HIF-2抑制剂

摘要

The present invention relates to inhibitors of HIF-1 and HIF-2 and uses thereof. The present invention further relates to the inhibitors for use in treatment of diseases. An isolated polypeptide is provided, that prevents dimerization of HIF-1α with HIF-1β and HIF-2α with HIF-1β and/or inhibits the activity of HIF-1 and HIF-2, wherein the polypeptide comprises the amino acid sequence C-X1-X2-X3-Z-X4 (SEQ ID NO: 1) and wherein X1, X2, X3 and X4 are any amino acid and wherein Z is leucine, valine of isoleucine or a non-natural derivative or leucine, valine or isoleucine. The isolated polypeptide prevents dimerization of HIF-1α with HIF-1β and HIF-2α with HIF-1β and inhibits the activity of HIF-1 and HIF-2 by binding to HIF-1α or HIF-1β and/or HIF-2α or HIF-1β.
机译:本发明涉及HIF-1和HIF-2的抑制剂及其用途。本发明还涉及用于治疗疾病的抑制剂。提供分离的多肽,其防止HIF-1α与HIF-1β和HIF-2α的二聚体与HIF-1β和/或抑制HIF-1和HIF-2的活性,其中所述多肽包含氨基酸序列C- X1-X2-X3-Z-X4(SEQ ID NO:1),其中X1,X2,X3和X4是任何氨基酸,其中Z是亮氨酸,异天酸盐或非天然衍生物或亮氨酸,缬氨酸或异亮氨酸。分离的多肽通过HIF-1β与HIF-1β和HIF-2α的HIF-1α与HIF-1β分二聚体,并通过与HIF-1α或HIF-1β和/或HIF-2α结合而抑制HIF-1和HIF-2的活性HIF-1β。

著录项

  • 公开/公告号US2021190791A1

    专利类型

  • 公开/公告日2021-06-24

    原文格式PDF

  • 申请/专利权人 UNIVERSITY OF SOUTHAMPTON;

    申请/专利号US202117194522

  • 发明设计人 ALI TAVASSOLI;

    申请日2021-03-08

  • 分类号G01N33/68;C07K7/06;C07K14/47;A61P35;A61K38/08;A61K38/18;C07K7/02;

  • 国家 US

  • 入库时间 2022-08-24 19:31:46

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号